Comprehensive Psychiatry
Volume 41, Issue 2, Supplement 1 , Pages 26-31 , March 2000

Does effective lithium prophylaxis result in a symptom-free state of manic-depressive illness? Some thoughts on the fine-tuning of mood stabilization

  • B. Müller-Oerlinghausen

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Prof. Dr. Med. B. Mller Oerlinghausen, Department of Psychiatry, Research Group of Clinical Psychopharmacology and Lithium Clinic Berlin, Freie Universität Berlin, Eschenallee 3, D-14050 Berlin, Germany.
    • Corresponding Author InformationAddress reprint requests to Prof. Dr. Med. B. Mller Oerlinghausen, Department of Psychiatry, Research Group of Clinical Psychopharmacology and Lithium Clinic Berlin, Freie Universität Berlin, Eschenallee 3, D-14050 Berlin, Germany.

References 

  1. Müller-Oerlinghausen B. Mental functioning. In: Johnson FN editors. Depression and Mania. Modern Lithium Therapy. Washington, DC: IRL Press; 1987;p. 246–252
  2. Müller-Oerlinghausen B. Towards a neuropsychological model of lithium action. Pharmacopsychiatry. 1987;20:192–194
  3. Schou M. The combat of non-compliance during prophylactic lithium treatment. Acta Psychiatr Scand. 1997;95:361–363
  4. Schon M. Probleme der Patienten mit der eigenen Wahrnehmung ihrer Krankheit und deren Langzeitbehandlung. Zusammenarbeit zwischen Arzt, Patient und Angehörigen. In: Müller-Oerlinghausen B, Greil W, Berghöfer A editor. Die Lithiumtherapie. Ed. 2. Berlin, Germany: Springer-Verlag; 1997;p. 570–579
  5. McAllister-Williams RH, Ferrier IN, Young AH. Mood and neuropsychological function in depression: the role of corticosteroids and serotonin. Psychol Med. 1998;28:573–584
  6. Keller MB, Lavori PW, Kane JM, Gelenberg AJ, Rosenbaum JF, Walzer EA, et al. Subsyndromal symptoms in bipolar disorder. Arch Gen Psychiatry. 1992;49:371–376
  7. Kröber HL, Adam R, Scheidt R. Einflüsse auf die Rückfälligkeit bipolar Manisch-Depressiver. Nervenarzt. 1998;69:46–52
  8. Nilsson A, Axelsson R. Psychopathology during long-term lithium treatment of patients with major affective disorders. Acta Psychiatr Scand. 1989;80:375–388
  9. (ISBN 91-7900-721-x) Nilsson A. Long-term lithium treatment of patients with major affective disorders. In: Doctoral Thesis. University of Göteborg; 1989;
  10. Kjellmann BF, Karlberg BE, Thorell LH. Cognitive and affective functions in patients with affective disorders treated with lithium-an assessment by questionnaire. Acta Psychiatr Scand. 1980;62:32–46
  11. Weingartner H, Rudorfer MV, Linnoila M. Cognitive effects of lithium treatment in normal volunteers. Psychopharmacology. 1985;86:472–474
  12. Vestergaard P, Poulstmp I, Schou M. Prospective studies on a lithium cohort. III. Tremor, weight gain, diarrhoea, psychological complaints. Acta Psychiatr Scand. 1988;78:434–440
  13. Smigan L, Perris C. Memory functions and prophylactic treatment with lithium. Psychol Med. 1983;13:529–537
  14. van Gent EM, Zwart FM. The effects of lithium carbonate and lithium citrate on cognitive function. Acta Ther. 1991;17:253–262
  15. Pons L, Numberger JI, Murphy DI. Mood-dependent aberrancies in associative processes in bipolar affective disorder: an apparent stabilizing effect of lithium. Psychiatry Res. 1985;14:315–322
  16. Kropf D, Müller-Oerlinghausen B. Changes in learning, memory, and mood during lithium treatment. Acta Psychiatr Scand. 1979;59:97–124
  17. Winters KC, Neale JM. Mania and low self-esteem. J Abnorm Psychol. 1985;94:282–290
  18. Wolf T. Die Rolle der kognitiven Verhaltenstherapie in der Langzeitprophylaxe. In: Müller-Oerlinghausen B, Greil W, Berghöfer A editor. Die Lithiumtherapie. Ed. 2. Berlin, Germany: Springer-Verlag; 1997;p. 528–534
  19. Volk J, Müller-Oerlinghausen B. Quality of interepisodic periods in patients with affective disorders under long-term lithium treatment. Pharmacopsychiatry. 1988;21:426–427
  20. Beck AT. Cognitive models of depression. J Cogn PsychotherInt Q. 1987;1:5–37
  21. Priebe S, Wildgrube C, Müller-Oerlinghausen B. Lithium prophylaxis and expressed emotion. Br J Psychiatry. 1989;154:396–399
  22. Goldstein MJ. Commentary on “Expressed Emotion in Depressed Patients and Their Partners”. In: Fam Proc. 31:1992;p. 172–174
  23. Rüger U. Tiefenpsychologische Aspekte des Verlaufs phasischer Depressionen unter Lithium-Prophylaxe. Nervenarzt. 1976;9:538–543
  24. Rüger U. Intrapsychische und familiendynamische Prozesse vor der manifesten Erkrankung und während der LithiumTherapie einer endogenen Depression. Z Psychosomat Med. 1977;23:329–350
  25. Gudohr C. Langzeitverlauf einer Lithiumprophylaxe bei endogenen Depressionen unter neurosenpsychologischen Gesichtspunkten. In: Inaugural-Dissertation. Freie Universität Berlin; 1985;
  26. Kline NA. Lithium and crisis intervention: damping affective overload. Psychosomatics. 1978;19:401–405
  27. Bonetti U, Johansson F, von Knorring L, Perris C, Strandman E. Prophylactic lithium and personality variables. Pharmacopsychiatry. 1977;12:14–19
  28. Schou M, Baastrup PC. Personal and social implications of lithium maintenance treatment. In: Ban TA, et al. editor. Psychopharmacology, Sexual Disorders and Drug Abuse. Amsterdam, The Netherlands: North-Holland; 1973;p. 65
  29. Müller-Oerlinghausen B. Psychological effects, compliance, and response to long-term lithium. Br J Psychiatry. 1982;141:411–419
  30. Johnson FN. The Psychopharmacology of Lithium. London, UK: Macmillan; 1984;
  31. Classen W. Der psychologische Zugang zur Wirkungsweise einer Lithiumprophylaxe. In: Müller-Oerlinghausen B, Greil W, Berghöfer A editor. Die Lithiumtherapie. Ed. 2. Berlin, Germany: Springer-Verlag; 1997;p. 118–136
  32. Sheard MH. Clinical pharmacology of aggressive behavior. Clin Neuropharmacol. 1984;7:173–183
  33. Thies-Flechtner K, Müller-Oerlinghausen B, Seibert W, Walther A, Greil W. Effect of prophylactic treatment on suicide risk in patients with major affective disorders. Data from a randomized prospective trial. Pharmacopsychiatry. 1996;29:103–107
  34. Kropf D, Müller-Oerlinghausen B. The influence of lithium long-term medication on personality and mood. Pharmacopsychiatry. 1985;18:104–105
  35. Barton DC, Dufer D, Monderer R, Cohen MJ, Fuller HJ, Clark MR, et al. Mood variability in normal subjects on lithium. Biol Psychiatry. 1993;34:878–884
  36. Insel TR, van Kammen DP, Cohen RM, Alterman IS, Murphy DL. Lithium and mood change in affective disorder patients. Biol Psychiatry. 1981;16:1051–1057
  37. Bouman TK, de Vries J, Koopamans IH. A prospective longitudinal comparison of euthymic bipolars and non-patient controls. J Affect Disord. 1992;24:199–206
  38. Correa EI, Folstein ME. Does lithium stabilize mood?. Biol Psychiatry. 1983;18:1093–1095
  39. Müller-Oerlinghausen B, Kropf D. Effects of lithium on normal experience and behavior. Conditional and descriptive approach to the structure of its action. In: Strömgren E, Schou M editor. Origin, Prevention, and Treatment of Affective Disorders. New York, NY: Academic Press; 1979;p. 41–64
  40. Müller-Oerlinghausen B, Hamann S, Herrmann WM, Kropf D. Effects of lithium on vigilance, psychomotoric performance, and mood. Pharmacopsychiatry. 1979;12:388–396
  41. Herrmann WM, Kropf D, Fichte K, Müller-Oerlinghausen B. Elektroenzephalographische und psychoexperimentelle Untersuchungen mit Lithium an gesunden Probanden. Pharmacopsychiatry. 1980;13:200–212
  42. Bente D, Scheuler W, Ulrich G, Müller-Oerlinghausen B. Effects of lithium on the EEG of healthy subjects and psychiatric patients: methods, results and hypotheses. In: Herrmann WM editors. EEG in Drug Research. Stuttgart, Germany: Fischer; 1982;
  43. Ulrich G, Scheuler W, Müller-Oerlinghausen B. Zur visuell-morphologischen Analyse des himelektrischen Verhaltens bei Patienten mit manisch-depressiven und schizoaffektiven Psychosen unter Lithiumprophylaxe. Fortschr Neurol Psychiatr. 1983;51:24–36
  44. Ulrich G, Frick K, Lewinsky M. Lithium and theoretical concept of dynamic restriction: a comparison of the effects on different levels of quantitative EEG analysis. Lithium. 1993;4:33–44
  45. Knapp S, Mandell AJ. Scattering kinetics in a complex tryptophan hydroxylase preparation from rat brainstem raphe nuclei: statistical evidence that the lithium-induced sigmoid velocity function reflects two states of available catalytic potential. J Neural Transm. 1983;58:169–182
  46. Kropf D, Müller-Oerlinghausen B. Assessment of visual perception by means of the signal detection theory in patients under lithium long-term treatment. Pharmacopsychiatry. 1985;18:102–103
  47. Kropf D. Der psychologische Zugang zur Prophylaxe akuter affektiver Psychosen mit Lithiumsalzen. In: Müller-Oerlinghausen B, Greil W editor. Die Lithiumtherapie. Ed. 1. Berlin, Germany: Springer-Verlag; 1986;p. 60–77
  48. Cooke RG, Robb JC, Young LT, Joffe RT. Well-being and functioning in patients with bipolar disorder assessed using the MOS 20-Item Short Form (SF-20). J Affect Disord. 1996;39:93–97
  49. Prien RF, Potter WZ. NIMH Workshop report on treatment of bipolar disorder. Psychopharmacol Bull. 1990;26:409–427
  50. Vestergaard P, Amdisen A. Patient attitudes towards lithium. Acta Psychiatr Scand. 1983;67:8–12
  51. O'Connell RA, Mayo JA, Eng LK, Jones IS, Gabel RH. Social support and long-term lithium outcome. Br J Psychiatry. 1985;147:272–275
  52. O'Connell RA, Mayo JA, Flatow L, Cuthbertson B, O'Brien BE. Outcome of bipolar disorder on long-term treatment with lithium. Br J Psychiatry. 1991;159:123–129
  53. van Gent EM, Zwart FM. A long follow-up after group therapy in conjunction with lithium prophylaxis. Nord J Psychiatry. 1994;48:9–12
  54. Cerbone MIA, Mayo JA, Cuthbertson BA, O'Connell RA. Group therapy as an adjunct to medication in the management of bipolar affective disorder. Group. 1992;16:174–187
  55. Seeger PA, Stern SL, Dennert JW. A combined group and individual approach to outpatient lithium treatment. Ohio Med. 1989;85:300–302
  56. Fava GA, Rafanelli C, Cazzaro M, Conti S, Grandi S. Well-being therapy. A novel psychotherapeutic approach for residual symptoms of affective disorders. Psychol Med. 1998;28:475–480
  57. Klerman GL, Weissman MM, Rounsaville BJ, Chevron ES. Interpersonal Psychotherapy of Depression. New York: NY Basic Books; 1984;
  58. Schramm E. Die Rolle der “Interpersonellen Therapie unter Regulierung der sozialen Rhythmik” in der Langzeitprophylaxe bipolarer Störungen. In: Müller-Oerlinghausen B, Greil W, Berghöfer A editor. Die Lithiumtherapie. Ed. 2. Berlin, Germany: Springer-Verlag; 1997;p. 535–544
  59. Stoll AL, Locke CA, Vuckovic A, Mayer PV. Lithiumassociated cognitive and functional deficits reduced by a switch to divalproex sodium: a case series. J Clin Psychiatry. 1996;57:356–359
  60. Coppen A, Abou-Saleh MT. Lithium therapy: from clinical trials to practical management. Acta Psychiatr Scand. 1988;78:754–762
  61. Schou M. The integrated approach. On the significance of pharmacological and nonpharmacological factors when lithium prophylaxis fails. Acta Psychiatr Scand Suppl. 1988;78:119–123

PII: S0010-440X(00)80005-X

Comprehensive Psychiatry
Volume 41, Issue 2, Supplement 1 , Pages 26-31 , March 2000

Article Tools